Total Funding
51
75
Total FundingSeries C raised
Growth Score
-3 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
10769
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
- Jonathan Montagu: President & Chief Executive OfficerPast Role: Nimbus Therapeutics, Chief Business Officer
- Geraldine Harriman: CSO & Co-FounderPast Role: Nimbus Therapeutics, VP & Head of Nimbus Apollo
About the Company
HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspot
structures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.
HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.
Women Founded
